Karl Swartling

Karl Swartling

No open positions remaining
61 year
Finance
Health Technology
Health Services

Profile

Mr. Karl A. Swartling is a Chief Executive Officer at Stena Sessan AB. He is on the Board of Directors at Affibody AB. Mr. Swartling was previously employed as a Managing Director by Sjätte AP-fonden, a Managing Director by Sjätte AP-fonden (Private Equity), a Managing Director by Investor Growth Capital AB, a Deputy Director by Atlas Antibodies AB, a Non-Executive Director by GHP Specialty Care AB, and a Principal by Mckinsey & Co., Inc. (Munich).
He also served on the board at Aerocrine AB, Cambio Healthcare Systems AB, Cellectricon AB, Global Health Partner Ltd., KTH Holding AB, Mando AB, Newron Sweden AB, PocketMobile Communications AB, Sörman Intressenter AB and Tobii AB. He received his MBA from Stockholm School of Economics.

Karl Swartling active positions

CompaniesPositionStart
Director/Board Member -

Former positions of Karl Swartling

CompaniesPositionEnd
Chief Executive Officer 2019-02-28
Chief Executive Officer 2019-02-28
President 2012-01-20
AEROCRINE AB Director/Board Member 2011-11-15
Mckinsey & Co., Inc. (Munich)
Corporate Officer/Principal -
See the detail of Karl Swartling's experience

Training of Karl Swartling

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

74

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies18

Electronic Technology

Commercial Services

Health Technology

Finance

Finance

Consumer Services

Health Technology

Health Services

Health Services

Electronic Technology

Health Technology

Technology Services

Finance

Health Services

Technology Services

Commercial Services

Finance

Mckinsey & Co., Inc. (Munich)

  1. Stock Market
  2. Insiders
  3. Karl Swartling
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!